Bone Biologics Corporation (BBLG) Stock

Bone Biologics Corporation (BBLG) is a Healthcare stock trading at $1.44 (as of 2026-06-18), with a market capitalization of $2.15M and a trailing P/E of -0.5. Figures are sourced from first-party U.S. SEC EDGAR filings and market data.

I can’t prepare a compliant description because the company’s SEC 10‑K “Business” (Item 1) text wasn’t provided. Please paste the Item 1 Business section so I can base the 1–2 sentence summary on the authoritative source.

Valuation — source: SEC EDGAR (first-party)
Price$1.44
Market Cap$2.15M
P/E Ratio-0.5
Price / Book0.48
DCF Value (model)$-22.55
DCF Upside vs Price-1666.0%
Profitability & Growth — source: SEC EDGAR
Revenue (TTM)$1.07B
Net Margin-0.2%
Return on Equity-61.2%
Current Ratio16.09
Valuation vs Sector & Industry
Stock P/E-0.5
Sector P/E (Healthcare)20.9
Industry P/E (Medical Equipment)31.7
vs Sector-102.2%
vs Industry-101.4%
Smart-Money Activity — SEC Form 4 / 13F / Congressional disclosures
Top Institutional HolderMORGAN STANLEY ($60763.00)
Institutional Holders Tracked7
Company
SectorHealthcare
IndustryMedical Equipment
CEOJeffrey Frelick
Employees2
CountryUS
IPO Date2021-10-13

Related Companies (Business model: Medical Devices / Life Science Tools; 8 closest by market cap; US-domiciled)

  • Astrotech Corporation (ASTC)
  • Innovative Eyewear, Inc. (LUCY)
  • HeartSciences Inc. (HSCS)
  • Sonoma Pharmaceuticals, Inc. (SNOA)
  • Nuwellis, Inc. (NUWE)
  • ENvue Medical, Inc. (FEED)
  • SeaStar Medical Holding Corporation (ICU)
  • Lifeward Ltd. (LFWD)
BBLG earnings history · BBLG institutional & insider holders · Congress trades · Insider trades · Short interest · Stock screener

Data as of 2026-06-18.

Figures sourced from U.S. Securities and Exchange Commission (SEC EDGAR) filings and market data. Not personalized investment advice.